Cargando…
The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
The phosphoinositide 3-kinase (PI3K) pathway is frequently activated in human cancer and represents an attractive target for therapies based on small molecule inhibitors. PI3K isoforms play an essential role in the signal transduction events activated by cell surface receptors including receptor tyr...
Autores principales: | Arcaro, Alexandre, Guerreiro, Ana S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652403/ https://www.ncbi.nlm.nih.gov/pubmed/19384426 http://dx.doi.org/10.2174/138920207782446160 |
Ejemplares similares
-
The phosphoinositide 3-kinase pathway and therapy resistance in cancer
por: Brown, Kristin K., et al.
Publicado: (2015) -
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics
por: Murthy, Divya, et al.
Publicado: (2018) -
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023) -
Phosphoinositide 3-Kinase C2β Regulates RhoA and the Actin Cytoskeleton through an Interaction with Dbl
por: Błajecka, Karolina, et al.
Publicado: (2012) -
Targeting the phosphoinositide-3-kinase/protein kinase B pathway in airway innate immunity
por: Gopallawa, Indiwari, et al.
Publicado: (2020)